Fig 1: Schematic model for the role of JMJD2D in protecting colonic epithelial cells from C. rodentium infection.C. rodentium infection activates NF-κB signaling to induce JMJD2D expression; on one hand, JMJD2D activates STAT3 signaling by enhance STAT3 phosphorylation; on the other hand, JMJD2D cooperates with STAT3 to promote IL-17F expression to further induce the expression of antimicrobial peptide β-defensins to eliminate C. rodentium by interacting with STAT3 and being recruited to the IL-17F promoter to demethylate H3K9me3.
Fig 2: Iron deficiency modulates MSC activation via the PI3K-Akt pathway. (A) Western blot analysis of KDM4D, H3K9me3, PIK3R3 and p-Akt expression in MSCs treated as indicated (n = 9). (B) Western blot analysis of p-Akt expression in MSCs treated as indicated (n = 9). (C) Flow cytometric detection of G0-phase MSCs treated as indicated (n = 9). (D) EdU staining for detecting activated MSCs treated as indicated (n = 9). (E) Western blot analysis of KDM4D, H3K9me3 and p-Akt expression in MSCs treated as indicated (n = 9). (F) Flow cytometric detection of G0-phase MSCs treated as indicated (n = 9). (G) EdU staining for detecting activated MSCs treated as indicated (n = 9)
Fig 3: Downregulation of JMJD2D inhibits the self-renewal of LCSC in vitro.A, JMJD2D protein levels were upregulated in LCSCs compared with non-CSCs (attached cells). B, downregulation of JMJD2D protein level by JMJD2D shRNAs and CRISPR-Cas9 system was confirmed by western blot analysis in HepG2, Huh-7, and Hepa1-6. C, downregulation of JMJD2D in liver cancer cells reduced tumorsphere number and size. D, the in vitro limiting dilution assay showed that downregulation of JMJD2D decreased CSC self-renewal frequency. E, The serial sphere formation assay showed that downregulation of JMJD2D decreased self-renewal capacities of LCSCs. These experiments were performed at least three times with similar results. ∗, p < 0.05; ∗∗, p < 0.01; ∗∗∗, p < 0.001; ∗∗∗∗, p < 0.0001.
Fig 4: TRIM14 reduces H3K9me3 through stabilizing KDM4D. (A) Flag-TRIM14–inducible HeLa cells were treated with the indicated concentration of Doxy for 12 h. Then, the cells were harvested for immunoblot analysis of H3K9me3 and KDM4D levels or to quantify the mRNA levels of TRIM14 and KDM4D. ImageJ software (NIH) was used to quantify the protein levels of KDM4D/β-actin. (B) Immunoblot analysis of KDM4D, H3K9me3 and TRIM14 in WT or TRIM14-KO HeLa cells treated with 100 ng/mL LPS, as indicated. The protein levels of KDM4D/β-actin and H3K9me3/H3 were analyzed by ImageJ software (NIH). (C) Immunoblot analysis of H3K9me3 and KDM4D in WT or Trim14−/− BMDCs treated with DMSO or IOX1 (50 μM, 3 h). (D) Immunoblot analysis of H3K9me3 levels in extracts of WT or KDM4D-KO HEK293T cells, with or without overexpressed HA-TRIM14. In A and B, data are mean values ± SEM and P values were calculated by unpaired two-tailed Student’s t test (three independent experiments). ns, not significant, *P < 0.05, **P < 0.01, ****P < 0.0001.
Fig 5: TRIM14 interacts with KDM4D to inhibit its autophagic degradation. (A) BMDCs were treated with 100 ng/mL LPS, 0.3 μM BafA1, and 5 μM MG132, and cell extracts were collected for co-IP and immunoblot analysis of the interaction of TRIM14 and KDM4D. The red asterisk indicates the band of heavy chains. WCL, whole-cell lysates. (B) HeLa cells were treated with 50 ng/mL TNF-α for 6 h, and then the cells were stained with anti-TRIM14 (red) and anti-KDM4D (green) antibodies, as well as DAPI (blue) to detect the colocalization of TRIM14 and KDM4D by confocal microscopy. (Scale bar, 10 μm.) Statistics shown refer to the correlation between TRIM14 and KDM4D in the indicated samples. (C) Immunoblot analysis of KDM4D stabilization in HEK293T cells transfected with Flag-KDM4D or HA-TRIM14, followed by DMSO, MG132 (5 μM), or 3MA (5 mM) treatment for 6 h. The protein levels of Flag-KDM4D/β-actin were quantified by ImageJ software (NIH). (D) Immunoblot analysis of KDM4D in WT or ATG5-KO HEK293T cells transfected with HA-TRIM14. (E) HeLa cells were transfected with Myc-TRIM14 and treated with EBSS for 3 h and 0.3 μM BafA1 for 6 h. Then, the cell extracts were harvested for co-IP and immunoblot analysis of the interaction of KDM4D and LC3 II. In B, the data show the mean values ± SEM, and P values were determined by unpaired two-tailed Student’s t tests (n = ∼50 cells). In C, data are mean values ± SEM and P values were calculated by unpaired two-tailed Student’s t tests (three independent experiments). ns, not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Supplier Page from Abcam for Anti-KDM4D / JMJD2D antibody